Adhera Therapeutics Inc (ATRX): I am thinking it might be more than a si...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Adhera Therapeutics Inc (ATRX)

Reply Private New

Keep Last Read

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	40
Posts	6225
Boards Moderated	0
Alias Born	05/21/2015

Re: EOT post# 3723

Friday, 02/02/2024 1:41:46 PM

Friday, February 02, 2024 1:41:46 PM

I am thinking it might be more than a simple 3500 payment. If it is though I'm good with that lol.

Could be something else the company needs to disclose.

Shares still increasing so debt still exists here. Need to see the 10q and an update.

Anything can happen here I've seen it all. Right now we are in the dark. But given what I have seen in the filings...the deal that just closed...and the share count...still hopeful here.

They didn't come all this way to go bankrupt....they could've just done that 3 years ago.

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent ATRX News

Form SEC STAFF ACTION - SEC Staff Action: ORDER • Edgar (US Regulatory) • 01/30/2024 09:00:03 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/18/2024 09:25:08 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/16/2024 09:01:16 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/29/2023 09:01:18 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:51:55 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 09:35:43 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/12/2023 08:58:43 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 07:32:22 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/15/2023 08:05:13 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/29/2023 08:54:24 PM

More ATRX News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow